<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02350907</url>
  </required_header>
  <id_info>
    <org_study_id>25/2013</org_study_id>
    <nct_id>NCT02350907</nct_id>
  </id_info>
  <brief_title>Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea</brief_title>
  <acronym>RaDAR-Go</acronym>
  <official_title>Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea: RaDAR-Go</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a laboratory-based assay that will be a real-time PCR
      test to detect the organism N. gonorrhoeae and its most important genetic markers of
      antimicrobial resistance. This study will also determine factors associated with gonorrhoea
      and describe sexual behaviours of men who have sex with men, to inform parameters for a
      mathematical model of gonorrhoea transmission and antimicrobial resistant gonorrhoea.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of N. gonorrhoeae genetic markers for antimicrobial resistance in clinical specimens</measure>
    <time_frame>Day of specimen sampling</time_frame>
  </primary_outcome>
  <enrollment type="Actual">261</enrollment>
  <condition>Gonorrhoea</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Swabs from the urethra, rectum, oropharynx, vagina and endocervix
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult male and females at risk of gonorrhoea infection.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is willing and able to give informed consent for participation in the
             study.

          -  Male or female, aged 18 years or above.

          -  Participant is literate in German, French, English or Hungarian.

          -  Participant is at risk for a N. gonorrhoeae infection. This is defined as:

               1. exhibiting signs/symptoms of a N. gonorrhoeae infection.

               2. having a sexual partner who has been diagnosed with a N. gonorrhoeae infection.

               3. participating in high-risk activities for a N. gonorrhoeae infection.

                  Exclusion Criteria:

          -  Subject does not agree to undergo diagnostic test for gonorrhoea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicola Low</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern, Institute of Social and Preventive Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulatorium Kanonengasse</name>
      <address>
        <city>Zurich</city>
        <zip>8004</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Checkpoint Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med. 2014 Feb 4;11(2):e1001598. doi: 10.1371/journal.pmed.1001598. eCollection 2014 Feb. Review.</citation>
    <PMID>24503544</PMID>
  </reference>
  <reference>
    <citation>Fingerhuth SM, Bonhoeffer S, Low N, Althaus CL. Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners. PLoS Pathog. 2016 May 19;12(5):e1005611. doi: 10.1371/journal.ppat.1005611. eCollection 2016 May.</citation>
    <PMID>27196299</PMID>
  </reference>
  <reference>
    <citation>Don√† V, Kasraian S, Lupo A, Guilarte YN, Hauser C, Furrer H, Unemo M, Low N, Endimiani A. Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae. J Clin Microbiol. 2016 Aug;54(8):2074-81. doi: 10.1128/JCM.03354-15. Epub 2016 May 25.</citation>
    <PMID>27225407</PMID>
  </reference>
  <reference>
    <citation>Low N, Unemo M. Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? Curr Opin Infect Dis. 2016 Feb;29(1):45-51. doi: 10.1097/QCO.0000000000000230. Review.</citation>
    <PMID>26658656</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2015</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antimicrobial resistance</keyword>
  <keyword>point-of-care testing</keyword>
  <keyword>Neisseria gonorrhoeae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gonorrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

